Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • deanie
    Junior Member
    • Apr 2014
    • 2

    Dealing with technical replicates

    First question, can anyone confirm these are indeed technical replicates?

    3 blood samples taken from the same individual, each processed separately and final libraries pooled for sequencing (paired-end). So have a pair of fastq files for each of the replicates.

    Second question, what are your opinions on how to deal with the technical replicates during differential expression analysis?

    I've heard of technical replicates sequenced over different lanes and then combining the fastqs. In this lab's experiment there is no lane variation due to the multiplexing. Is it still sensible to combine them in the case described above?

    Or separately process the fastqs for each replicate (i.e. qc, trimming, counts) and then combine the read counts? Based on what I read most people sum the counts of the technical replicates, with a few posts suggesting averaging them.

    TIA!
  • gringer
    David Eccles (gringer)
    • May 2011
    • 845

    #2
    It is a type of technical replicate, but will have some degree of biological variation from the different samples. Usually "technical replicate" refers to an additional sequencing library prepared from the same extract.

    In this case because there is a chance of biological variation, I would keep the samples separate and add the sample as an additional factor in any statistical models.

    Comment

    • deanie
      Junior Member
      • Apr 2014
      • 2

      #3
      Thanks gringer. It does seem a little grey compared to other examples of technical and biological replicates I've seen. I expect the biological variation to be limited as it is a blood sample taken at once (i.e. fingerprick and three 10ul samples taken).

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      12 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      30 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      41 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-08-2026, 10:08 AM
      0 responses
      26 views
      0 reactions
      Last Post SEQadmin2  
      Working...